Characterising the castration-resistant prostate cancer population: a systematic review

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expanding Treatment Options for Metastatic Prostate Cancer

(2011) Emmanuel S. Antonarakis et al.   NEW ENGLAND JOURNAL OF MEDICINE

PCN17 CASTRATION-RESISTANT PROSTATE CANCER (CRPC): A UK EPIDEMIOLOGY STUDY

(2011) C Morgan et al.   VALUE IN HEALTH

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Castration-Resistant Prostate Cancer: Descriptive Yet Pejorative?

(2010) E. David Crawford et al.   JOURNAL OF CLINICAL ONCOLOGY

Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)

(2010) Mette Nørgaard et al.   JOURNAL OF UROLOGY

Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population

(2010) B. Alemayehu et al.   JOURNAL OF MEDICAL ECONOMICS

Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy

(2009) Robert Abouassaly et al.   CANCER

Docetaxel-related side effects and their management

(2009) Jackie Baker et al.   European Journal of Oncology Nursing

Prevalence of Skeletal Complications and Their Impact on Survival of Hormone Refractory Prostate Cancer Patients in Japan

(2009) Takamitsu Inoue et al.   UROLOGY

EAU Guidelines on Prostate Cancer

(2007) Axel Heidenreich et al.   EUROPEAN UROLOGY